
Champions Oncology, Inc.
Oncology CRO accelerating drug development with PDX models, multi-omic data, and analytics.
CSBR | NDAQ
Overview
Corporate Details
- ISIN(s):
- US15870P3073
- LEI:
- 549300O8WKLP8QEG5U47
- Country:
- United States of America
- Address:
- N/A
- Website:
- www.championsoncology.com
- Sector:
- Industry:
Description
Champions Oncology, Inc. is a global contract research organization (CRO) specializing in accelerating oncology drug development. It partners with pharmaceutical and biotech companies to provide end-to-end solutions, from preclinical research to clinical specialty testing. The company's foundation is its proprietary, clinically relevant bank of over 1,400 Patient-Derived Xenograft (PDX) models. This is integrated with a comprehensive multi-omic data platform containing over two billion data points, accessible to researchers through the Lumin analytics software. Champions also offers advanced analytical services, including high-complexity flow cytometry and next-generation sequencing, to support programs from target discovery to clinical success.
Unlock This Filing & Millions More
You're one step away from the data you need. Create a free account to instantly view this filing and get access to powerful research tools.
Filings
Date | Filing | Language | Size | Actions | |
---|---|---|---|---|---|
No filings match the current criteria. |
Automate Your Workflow. Get a real-time feed of all Champions Oncology, Inc. filings delivered via API.
Market Data
Market Data Not Available
Financials & KPIs
No Financial Data Available
Standardized financial statements for the selected period are not yet available.
Need More History? Access decades of standardized financials for Champions Oncology, Inc. via our API.
Insider Transactions
Date | Insider Name | Position | Type | Shares | Value |
---|---|---|---|---|---|
No insider transactions recorded for this company. |
Peer Companies
Company | Country | Ticker | View | |
---|---|---|---|---|
No peer companies found in this sub-industry. |